富士莱 (301258)
Suzhou Fushilai Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 9167.00
- Circulating A-Shares(W): 8906.50
- Earnings Per Share(RMB): 0.8099
- Net Assets Per Share(RMB): 20.8534
- Operating Revenue(W RMB): 32258.47
- Total Profit(W RMB): 8629.10
- Net Profit Attributable to Parent(W RMB): 7339.66
- Net Profit Growth Rate(%): 430.16
- Weighted Return on Equity(%): 3.8300
- Operating Cash Flow Per Share(RMB): 0.6480
- Undistributed Profit Per Share(RMB): 7.5281
- Capital Reserve Per Share(RMB): 12.4755
2. Main Business
The main business covers:
- R&D, production and sales of pharmaceutical intermediates
- R&D, production and sales of active pharmaceutical ingredients (APIs)
- R&D, production and sales of health product raw materials
3. Company Basic Information
- Company Name: Suzhou Fushilai Pharmaceutical Co., Ltd.
- Listing Date: 2022-03-29
- Industry: Pharmaceutical Manufacturing
- Address: No. 16 Haiwang Road, Changshu New Material Industrial Park, Jiangsu Province
- Website: www.fuslai.com
- Company Profile: The company, formerly known as Suzhou Fushilai Pharmaceutical Co., Ltd., was established on September 12, 2013 through the overall change of Fushilai Co., Ltd. The company is mainly engaged in the R&D, production and sales of pharmaceutical intermediates, APIs, and health product raw materials. The company was listed on the ChiNext Board of the Shenzhen Stock Exchange on March 29, 2022.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Suzhou Fushilai Technology Service Development Center (Limited Partnership) | General Legal Person | 5520.00 | 61.94 |
| 2 | Wentian Private Securities Investment Fund Management (Guangzhou) Co., Ltd. - Wentian Runze Private Securities Investment Fund | Private Securities Investment Fund | 56.10 | 0.63 |
| 3 | Galaxy Kangle Stock Securities Investment Fund A Class | Fund | 17.81 | 0.20 |
5. Concept Sectors
- Venture Capital Concept
- Vitamin
- Medical Aesthetics Concept
- Synthetic Biology
- Margin Trading & Securities Lending
- Below IPO Price
- Micro & Small Cap Stocks
- CSI Repurchase Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information